Clinical Trials
>
Urinary Tract / Bladder Cancer

PCYC-1128-CA

A Phase1b/2 Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal and Genitourinary Tumors (Bladder, Colon, Gastric, Renal).

W030070

A Phase III, Randomized,Placebo Controlled Study Of ATEZOLIZUMAB(ANTI-PD-L1 ANTIBODY) As Monotherapy And In Combination With Platinum Chemotherapy In Patients With Untreated Locally Advanced Or Metastatic Urothelial Carcinoma.

S1605

Phase II Trial of Atezolizumab in BCG-Unresponsive Non- Muscle Invasive Bladder Cancer.